Sie sind auf Seite 1von 2

FERRIMED SYRUP (syrup)

1 of 2

http://home.intekom.com/pharm/byk/ferysyr.html

INDICATIONS

CONTRAINDICATIONS DOSAGE SIDEEFFECTS PREGNANCY


IDENTIFICATION PATIENT INFORMATION

OVERDOSE

FERRIMED SYRUP (syrup)


SCHEDULING STATUS
Not scheduled
PROPRIETARY NAME
(and dosage form)

FERRIMED SYRUP (syrup)


COMPOSITION
Each 5 mL contains iron polymaltose complex equivalent to 50 mg elemental iron
Preservative: methylhydroxybenzoate 0,0583% m/v
propylhydroxybenzoate 0,0167% m/v
PHARMACOLOGICAL CLASSIFICATION
A 8.3 Erythropoietics (haematinics).
PHARMACOLOGICAL ACTION
Iron is an essential constituent of the body being necessary for haemoglobin formation and for the oxidative processes of
living tissue.
INDICATIONS
Treatment of iron deficiency anaemia.
CONTRAINDICATIONS
Hypersensitivity to any of the ingredients.
DIRECTIONS FOR USE
Adults:

5 mL 10 mL three times per day immediately after meals

Children (612 years):

50 mg to 100 mg of elemental iron per day i.e. 5 mL once or twice per day
immediately after meals

Children (26 years):

50 mg of elemental iron per day i.e. 2,5 to 5 mL once or twice per day immediately
after meals

Infants (5 10 kg):

25 mg of elemental iron per day i.e. 2,5 to 5 mL once daily immediately after meals

Premature babies (less than


1500 g):

3 mg of elemental iron/kg body weight daily

SIDEEFFECTS AND SPECIAL PRECAUTIONS


The oral administration of iron preparations sometimes produces gastrointestinal irritation with vomiting and diarrhoea.
Continued administration may sometimes produce constipation. The faeces may be coloured black.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT
Initially epigastric pain, diarrhoea and vomiting; and may include metabolic acidosis, convulsions, and coma after apparent
recovery. Speed is essential for effective treatment which is dependent upon removing excess iron from the alimentary

18-09-2016 00:26

FERRIMED SYRUP (syrup)

2 of 2

http://home.intekom.com/pharm/byk/ferysyr.html

tract prior to absorption. Initially an emetic should be given, followed by gastric lavage with 1% sodium bicarbonate, and
oral administration of desferrioxamine to complex with residue. Fluid loss may be made good with IV normal saline or
dextrose solution.
IDENTIFICATION
Dark brown caramel tasting syrup
PRESENTATION
Glass bottles containing 25 mL (with a dropper) and 100 mL
STORAGE INSTRUCTIONS
Store in a cool dark dry place below 25C.
KEEP OUT OF REACH OF CHILDREN.
REGISTRATION NUMBER
H842 (Act 101/1965)
NAME AND BUSINESS ADDRESS OF APPLICANT
Swisspharm (Pty.) Ltd.
Reg. No. 82/05646/07
Subsidiary of
Byk Gulden S.A. (Pty. Ltd.
Bryanston Gate 2
170 Curzon Road
BRYANSTON
2021
DATE OF PUBLICATION OF THIS PACKAGE INSERT
17 December 1974
Manufactured under licence to: Vifor (International) Inc.
SAEPI HOME PAGE

TRADE NAME INDEX

GENERIC NAME INDEX

FEEDBACK

Information presented by Malahyde Information Systems Copyright 1996,1997,1998

18-09-2016 00:26